Results 181 to 190 of about 11,167,014 (325)

Intravenous immunoglobulin as an adjunct to phototherapy in neonatal haemolytic disease: A systematic review and meta‐analysis

open access: yesTransfusion Medicine, EarlyView.
Abstract Phototherapy remains the first‐line treatment of haemolytic disease of the newborn (HDN), a potentially life‐threatening condition caused by maternal alloimmunisation. Intravenous immunoglobulin (IVIG) has been proposed as an adjunct to reduce the need for exchange transfusion (ET), a procedure associated with significant risks.
Megan Roberts   +11 more
wiley   +1 more source

The Role of ABO Blood Type in Patients with SARS-CoV-2 Infection: A Systematic Review. [PDF]

open access: yesJ Clin Med, 2022
Banchelli F   +6 more
europepmc   +1 more source

Prehospital whole blood transfusion versus component therapy—A scoping review

open access: yesTransfusion, EarlyView.
Abstract Background Whole blood has gained a foothold over component therapy in civilian emergency care, especially in emergency departments. In a prehospital setting, whole blood might be the logistically easier alternative compared to component therapy. However, most previous studies have been conducted in the emergency room setting.
Laura Muurinen   +3 more
wiley   +1 more source

Stacking platelet bags: A practical storage configuration for maintaining platelet quality during cold storage

open access: yesTransfusion, EarlyView.
Abstract Background As cold‐stored platelets (CSPs) are being integrated into clinical practice, it is necessary to determine the storage practices that best support platelet quality while remaining operationally feasible. Platelet components are traditionally stored at room temperature, in a single layer, to facilitate gas exchange.
Janhavi Mahajan   +5 more
wiley   +1 more source

Alpha‐gal sensitization and the transfusion medicine diagnostic gap: A single‐center study with multi‐institutional TriNetX validation

open access: yesTransfusion, EarlyView.
Abstract Background Transfusion‐related‐alpha‐gal syndrome (TRAGS) is an emerging transfusion complication in which alpha‐gal (α‐Gal)‐sensitized recipients may experience allergic reactions to B antigen‐containing plasma‐rich blood products. Group O recipients appear to be at greatest risk; group A recipients may also be at risk, whereas group B/AB ...
Homayemem K. Weli   +6 more
wiley   +1 more source

Frequency of ABO/Rhesus Blood Groups in Patients with Diabetes Mellitus

open access: yes, 2016
WOS: 000369703500021PubMed ID: 26787039The correlation between ABO/Rh blood groups and diabetes mellitus is still controversial. The aim of this study was to determine the relationship between ABO/Rhesus blood groups and diabetes in Turkish population ...
Yagan, Canan Fidan Celik   +4 more
core   +1 more source

Blocking FcγRI and FcγRIII reduces RBC phagocytosis induced by patient‐derived anti‐E and anti‐K alloantibodies in vitro

open access: yesTransfusion, EarlyView.
Abstract Introduction/Objectives Red blood cell (RBC) alloantibodies can cause hemolytic transfusion reactions and complicate compatible blood provision. Although antibody‐opsonized RBCs are thought to be cleared partly through macrophage Fcγ receptor‐mediated phagocytosis, the Fcγ receptors involved in phagocytosis induced by non‐D alloantibodies ...
Yaima Tundidor Cabado   +13 more
wiley   +1 more source

ABO blood type concordance-dependent variations in umbilical cord blood: Insights from twin pregnancies. [PDF]

open access: yesTransfusion
Nguyen VT   +8 more
europepmc   +1 more source

A retrospective evaluation of responsiveness to platelets in plasma and pathogen‐reduced platelets in platelet additive solution at a single institution

open access: yesTransfusion, EarlyView.
Abstract Background Studies suggest that recipients of pathogen reduced (PR) platelets in platelet additive solution (PAS) experience inferior increments when compared to platelets in plasma (PS); however, few real‐world studies have confirmed these observations. In this single‐center study, we evaluated responses to PS and PAS/PR platelets in platelet‐
Olivia McClellan   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy